心脏瓣膜介入治疗新器械专题会 XI
Symposium on Novel Devices for Cardiac Valve Interventional Therapy XI
04/18 15:40-17:40
杭州厅6&7 (Room Hangzhou 6&7)
-
15:40-17:40
-
15:40-17:40
-
15:40-17:40
-
15:40-17:40
-
15:40-17:40讨论嘉宾Panelist陈魁(CHEN Kui) (郑州大学第一附属医院), 丛广志(CONG Guang-Zhi) (宁夏医科大学总院), 方敏华(FANG Min-Hua) (北部战区总医院), 韩宇(HAN Yu) (阜外华中心血管病医院), 刘湘玮(LIU Xiang-Wei) (中南大学湘雅医院), 李华(LI Hua) (昆明市延安医院), 罗骏(LUO Jun) (南方医院赣州医院), 潘文志(PAN Wen-Zhi) (复旦大学附属中山医院), 彭小平(PENG Xiao-Ping) (南昌大学第一附属医院), 石凤梧(SHI Feng-Wu) (河北医科大学第二医院), 宋会军(SONG Hui-Jun) (中国医学科学院阜外医院深圳医院), 王正忠(WANG Zheng-Zhong) (青岛市市立医院), 杨文艺(YANG Wen-Yi) (上海市第一人民医院), 孙煌(SUN Huang) (昆明医科大学第一附属医院), 俞飞成(YU Fei-Cheng) (浙江大学医学院附属邵逸夫医院), 尹秋林(YIN Qiu-Lin) (江西省人民医院), 钟禹成(ZHONG Yu-Cheng) (广西壮族自治区人民医院)
-
15:40-16:21疗法方向之争：低龄时代是否已经到来？Debate on Therapeutic Direction: Has the Era of Younger Patients Arrived?
-
15:40-15:41开场致辞Opening Remarks
-
15:41-15:49ESC瓣膜性心脏病管理指南解读Interpretation of the ESC Guidelines for the Management of Valvular Heart Disease
-
15:49-15:57TAVR低龄低危适应证循证Evidence for TAVR in Low-risk, Younger Patients: Expanding Indications
-
15:57-16:07ESC指南发布后，欧洲TAVR真实世界应用情况Real-World Application of TAVR in Europe Following the ESC Guidelines Update
-
16:07-16:17ESC指南发布后，南美洲TAVR真实世界应用情况Real-World Application of TAVR in Latin America Following the ESC Guidelines Update
-
16:17-16:21问答Q&A
-
16:21-17:06技术路径之争：自膨 vs 球扩 谁更有优势？Debate on Technical Path: Self-Expandable Valve vs. Balloon-Expandable Valve, Which Is More Advantageous?
-
16:21-16:26冠脉高风险风湿性主动脉瓣狭窄一例A Case of Rheumatic Aortic Stenosis with High Coronary Risk
-
16:26-16:36讨论Discussion
-
16:36-16:41
-
16:41-16:51讨论Discussion
-
16:51-16:56
-
16:56-17:06讨论Discussion
-
17:06-17:41肺瓣专场Pulmonary Valve Special Session
-
17:06-17:16肺瓣患者全生命周期管理Lifecycle Management of Patients with Pulmonary Valve Disease
-
17:16-17:21讨论Discussion
-
17:21-17:31VenusP-Valve在复杂病例中的应用Application of VenusP-Valve in Complex Cases
-
17:31-17:36讨论Discussion
-
17:36-17:41致结束语Closing Remarks